Media, investors, advocacy organizations and others, please contact us here.

Patients with Newly Diagnosed IgAN Demonstrated Stable eGFR with First-Line Sparsentan (SPAR) over Two Years in the SPARTAN Final Analysis

Page 1 / 1 100%
Loading...